Updates are available Correction dated 2025-09-24
Click to view Correction: https://doi.org/10.1038/s41591-025-04017-7
-
Authors
Keeley, Alexander J. https://orcid.org/0000-0001-9386-1157
Camara, Fatoumata E.
Armitage, Edwin P.
de Crombrugghe, Gabrielle
Sillah, Jainaba
Fofana, Modou Lamin
Rollinson, Victoria
Senghore, Elina
Jammeh, Musukoi
Whitcombe, Alana L. https://orcid.org/0000-0002-1951-3469
Bittaye, Amat
Ceesay, Haddy
Ceesay, Isatou
Samateh, Bunja
Manneh, Muhammed
Carducci, Martina https://orcid.org/0000-0001-6633-567X
Rovetini, Luca
Boero, Elena https://orcid.org/0000-0001-7199-6456
Massai, Luisa
Sanyang, Lady Chilel
Camara, Ousman
Cessay, Ebrima E.
Iturriza, Miren
Moriel, Danilo Gomes https://orcid.org/0000-0002-1421-8129
Kucharski, Adam
Smeesters, Pierre R.
Botteaux, Anne
Jagne, Ya Jankey
Moreland, Nicole J. https://orcid.org/0000-0001-6548-637X
Clarke, Ed
Kampmann, Beate https://orcid.org/0000-0002-6546-4709
Marks, Michael
Rossi, Omar
Salje, Henrik https://orcid.org/0000-0003-3626-4254
Turner, Claire E.
de Silva, Thushan I. https://orcid.org/0000-0002-6498-9212
-
Funding
Funding for this research was provided by:
Wellcome Trust (225467/Z/22/Z, 222927/Z/21/Z)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 30 June 2025
First Online: 8 August 2025
Change Date: 24 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-025-04017-7
Competing interests
: A.J.K. received training in immunoassay development and delivery from the GSK Vaccines Institute for Global Health, an affiliate of GlaxoSmithKline (GSK). GSK had no role in overall study design, data analysis or data interpretation for this study. O.R., M.C., E.B., L.R., L.M., M.I. and D.G.M. are employees of the GSK Vaccines Institute for Global Health. A.B. and P.R.S. are inventors on a submitted patent related to Streptococcus pyogenes vaccines. The other authors declare no competing interests.
